title: Risks in the use of an unblinded-control group.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Skoler
authors.forename: Sumen
authors.initials: S
authors.lastname: Govender
authors.forename: Lydia
authors.initials: L
authors.lastname: Altini
authors.forename: Khatija
authors.initials: K
authors.lastname: Ahmed
authors.forename: Donald
authors.initials: D
authors.lastname: Waldron
authors.forename: Landon
authors.initials: L
authors.lastname: Myer
authors.forename: Pekka
authors.initials: P
authors.lastname: Lahteenmaki
mesh_terms: D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000494:pharmacology; D017280:Condoms / Q000706:statistics & numerical data; D018849:Controlled Clinical Trials as Topic / Q000009:adverse effects* / Q000379:methods* / Q000592:standards; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D012015:Reference Standards; D012107:Research Design; D012306:Risk; D018570:Risk Assessment
chemical_list: D000891:Anti-Infective Agents, Local